Hypoglossal nerve stimulation (HGNS) is a promising surgical option for patients with obstructive sleep apnea (OSA) who are intolerant of continuous positive airway pressure therapy (CPAP). Efficacy studies for HGNS stimulation largely focus on the apnea–hypopnea index and/or oxygen desaturation index. This study's objective was to show the physiological effects of HGNS stimulation on upper airway patency, airflow, and treatment effect during polysomnography (PSG) testing.
Analysis of on–off periods of HGNS therapy during PSG allows for a concise assessment of HGNS efficacy. The presence of inspiratory flow limitation and subsequent apneas or hypopneas upon turning off HGNS stimulation with restoration of stable, unobstructed breathing upon resuming HGNS stimulation indicates a positive treatment effect related to HGNS therapy. Despite the respiratory-sensing capacity of the Inspire HGNS device, desynchrony of stimulation and inspiration is observed. Desynchrony yields partially captured inspiratory cycles, allowing for assessment of HGNS effect on an individual breath.
Conclusion
Night-to-night and intranight variability in OSA severity makes assessing the effect of HGNS complex. Strategic testing protocols during postoperative PSG can provide critical insight into the effect of this therapy on upper airway obstruction during sleep. On–off periods of stimulation provide a concise assessment of the effect of HGNS on preventing upper airway collapse and help to account for night-to-night and intranight variability. Respiratory desynchrony associated with HGNS therapy exists. Observing partially-stimulated inspiratory cycles allow for assessment of HGNS's effect on a single breath.